Follicular dendritic cell sarcoma of small intestine with aberrant T-cell marker expression
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-11-01
著者
-
MATSUNO Yoshihiro
Department of Surgical Pathology, Hokkaido University Hospital
-
HAGA Hironori
Department of Pathology, Kyoto University Hospital
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Nagashima Kazuo
Departments of Cardiovascular Medicine and Pathology, Hokkaido University School of Medicine
-
Matsuno Yoshihiro
Department Of Cell Biology Tokai University School Of Medicine
-
KUBOTA Kanako
Department of Surgical Pathology, Hokkaido University Hospital
-
YAMADA Yosuke
Department of Surgical Pathology, Hokkaido University Hospital
-
Nagashima Kazuo
Department Of Pathology Sapporo Higashi-tokushukai Hospital
-
Nagashima Kazuo
Department Of Cellular Pathology Graduate School Of Medicine Hokkaido University
-
Kubota Kanako
Department Of Surgical Pathology Hokkaido University Hospital
-
Yamada Yosuke
Department Of Surgical Pathology Hokkaido University Hospital
-
Haga Hironori
Department Of Diagnostic Pathology Kyoto University Hospital
-
Haga Hironori
Department Of Surgical Pathology Hokkaido University Hospital
-
Hernandez Mako
Department Of Surgical Pathology Hokkaido University Hospital
-
ORII Fumika
Department of Internal Medicine, Sapporo Higashi Tokushukai Hospital
-
Orii Fumika
Department Of Internal Medicine Sapporo Higashi Tokushukai Hospital
-
Yamada Yosuke
Department Of Surgical Pathology Hokkaido University Graduate School Of Medicine
-
Kubota Kanako
Department Of Pathology Hokkaido University Hospital
-
Yamada Yosuke
Department Of Bioscience Graduate School Of Science And Technology Kwansei-gakuin University
-
NAGASHIMA Kazuo
Department of Pathology, Sapporo Higashi-Tokushukai Hospital
-
Haga Hironori
Department of Diagnostic Pathology Graduate School of Medicine, Kyoto University
関連論文
- Intracranial Extracerebral Neuroblastoma Originating from the Convexity Dura Mater : Case Report
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- A case of HIV-associated lymphoproliferative disease that was successfully treated with highly active antiretroviral therapy
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
- Successful cord blood transplantation for mycosis fungoides.
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- Melanocytic medulloblastoma with ganglioneurocytomatous differentiation : A case report
- Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells
- Conditioning Regimen of Melphalan, Fludarabine and Total Body Irradiation in Unmanipulated HLA Haploidentical Stem Cell Transplantation Based on Feto-maternal Tolerance
- Adenocarcinomatosis of the Bone Marrow and Secondary Acute Myeloid Leukemia
- Primary Cutaneous Diffuse Large B Cell Lymphoma : A Clinically Aggressive Case
- Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy : A multi-institutional study
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- -345-LOCALIZATION OF ATRIAL NATRIURETIC PEPTIDE IN HUMAN VENTRICULAR SYSTEM : Atrial Natriuretic Polypeptide : FREE COMMUNICATIONS(II) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- Anti-Hu paraneoplastic syndrome presenting with brainstem-cerebellar symptoms and Lambert-Eaton myasthenic syndrome
- Clinicopathological studies of peripheral neuropathy in Churg-Strauss syndrome
- RT-PCR ANALYSIS OF TYPEL ANGIOTENSIN-II RECEPTOR WITH RELATION TO THE HUMAN HEART
- LOCALIZATION OF ANGIOTENSINCONVERTING ENZYME(ACE)IN HUMAN HEART
- In situ hybridization using digoxigenin labeled DNA probe to detect viral genomes
- Expression of amyloid precursor protein mRNA in vascular smooth muscle cells of the human brain
- Successful Resection of Dermatomyositis Associated with Thymic Carcinoma : Report of a Case
- Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- APPEARANCE OF INTOXICATION IN RATS BY INTRAPERITONEAL ADMINISTRATION OF CLIOQUINOL
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors
- Epstein-Barr virus-positive diffuse large B-cell lymphoma carrying a t(9;14)(p13;q32) translocation
- IMPROVEMENT OF THE SIGNAL/NOISE RATIO ON ENZYME-IMMUNO-HISTO IN SITU HYBRIDIZATION
- Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
- Unrelated Donor Marrow Transplantation for Congenital Immunodeficiency and Metabolic Disease : An Update of the Experience of the Japan Marrow Donor Program
- Intravascular large B cell lymphoma : proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition
- Reappraisal of BCL3 as a Molecular Marker of Anaplastic Large Cell Lymphoma
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Primary Mediastinal Large B-Cell Lymphoma: A Comparative Study With Nodular Sclerosis-Type Hodgkin's Disease
- Synchronous presentation of Epstein-Barr virus-associated Hodgkin's disease and adult T-cell leukemia/lymphoma (ATLL) in a patient from an endemic area of ATLL
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Intracerebral schwannoma in a child with infiltration along perivascular spaces resembling meningioangiomatosis
- EBV-associated diffuse large B-cell lymphoma arising in the chest wall with surgical mesh implant
- Follicular dendritic cell sarcoma of small intestine with aberrant T-cell marker expression
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- IgG4-Related Disease : A Novel Lymphoproliferative Disorder Discovered and Established in Japan in the 21st Century
- Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- IgG4-related disease : Historical overview and pathology of hematological disorders
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
- A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement : The Nagasaki Transplant Group experience
- Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma
- Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility
- Late effect of Atomic bomb radiation on myeloid disorders : leukemia and myelodysplastic syndromes
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Use of tissue microarrays and immunohistochemistry to standardize the diagnosis of gastrointestinal stromal tumors